Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Rep. Mike Collins (R-Ga.) heavily criticized statements made by the Right Rev. Mariann Budde on Tuesday at the inaugural ...

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Millions of us take vitamins, minerals, and other supplements daily to improve our health and well-being—but taking certain ...

Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to Johnson & Johnson.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

But many people who take daily medications are unaware that certain drugs in their pill box can also increase their risk of ...

A panel of Colorado lawmakers approved a bill that would legalize synthetic psilocybin medications for certain conditions, contingent upon approval by the FDA.